Navigation Links
Promising New Therapy for Drug-Resistant Hypertension Presented at Interventional Cardiology Meeting in Washington, D.C.
Date:9/23/2010

is therapy in early 2011 commercialization in 2-3 years.

Other studies featuring the Mercator Micro-Infusion Catheter platform that were also presented this week at the TCT include presentations by Marc Penn, MD, PhD, Director, the Skirball Laboratory of Cardiovascular Cellular Therapeutics as part of the symposium entitled Strategies for Cardiovascular Repair: Stem Cell Therapy and Beyond; and John Karanian, PhD, Director of the Laboratory for Cardiovascular and Interventional Therapeutics, Office of Science and Engineering Labs, Center for Devices and Radiological Health, Food and Drug Administration, as part of the Carotid and Endovascular Intervention Symposium and as part of the Drug-Eluting Stent Summit.

About Mercator MedSystems, Inc.

Mercator MedSystems, Inc. (http://www.MercatorMed.com),  a privately-held medical device company headquartered in San Leandro, Calif., is developing targeted safe and effective therapies that reduce the expense of treating disease. Mercator is integrating the FDA-cleared Micro-Infusion Catheter with new and repurposed biotherapeutic agents to meet life-threatening medical needs in hypertension, cardiovascular disease, oncology and regenerative medicine. Mercator catheters are also used by several pharmaceutical and biotechnology companies to aid in the development of therapeutics that benefit from the direct targeting and efficiency of site-specific delivery.


'/>"/>
SOURCE Mercator MedSystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Promising Cystic Fibrosis Compound on Track for Development
2. Kiadis Pharma Announces Promising Phase II Clinical Trial Results for Reviroc
3. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
4. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
5. The Leukemia & Lymphoma Society is Encouraged by Promising News for Myeloma Patients
6. Promising Results in Treating Facial Bruising From Injectables
7. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
8. Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
9. Cutanea Announces Promising Phase II Results in Rosacea with Omiganan
10. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
11. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015 Sequent ... on developing innovative devices for the treatment of ... Kleine has joined its Board of Directors. ... years of medical device and healthcare industries experience. ... where he has commercialized numerous leading-edge products.  His ...
(Date:7/7/2015)... , July 7, 2015 Accelovance, ... focusing in Oncology, Vaccines, and General Medicine announced ... final locked database to Heron Therapeutics, Inc. for ... receptor antagonist product candidate SUSTOL® (granisetron injection, ... with the IV NK 1 receptor antagonist ...
(Date:7/7/2015)... Arentz Law Group is currently investigating cases of birth defects ... have taken Zyban while pregnant, and given birth to a ... the law firm immediately for a free legal consultation ... American Journal of Obstetrics & Gynecology  showed that mothers who ... birth to a child with " left outflow tract heart ...
Breaking Medicine Technology:Sequent Medical Appoints Mike Kleine to its Board of Directors 2Sequent Medical Appoints Mike Kleine to its Board of Directors 3Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2Smoking cessation drug linked to birth defects when taken during pregnancy 2
(Date:7/7/2015)... Boston, MA (PRWEB) , ... July 07, 2015 , ... ... , AIDS Action Committee of Massachusetts , and the Multicultural AIDS Coalition ... bisexual, and other men who have sex with men (MSM) and transgender women, the ...
(Date:7/7/2015)... ... ... Quadrino Law Group is pleased to announce the relocation of the firm's headquarters ... facility is a state of the art building, located with easy access to New ... founder, said, "We are pleased to service our clients from such a premier location ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... and development solutions for drugs, biologics and consumer health products, today announced ... access its antibody combination therapy (ACT) technology platform. The platform has the ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Summer is a ... precautions, however, so Amica Insurance is sharing some safety tips. , Jean Tapley, senior ... gardening: , Leisure activities/sports, , Start slowly. Going from no ...
(Date:7/7/2015)... ... July 07, 2015 , ... On Saturday, May 16th, 2015, ... the Manistee Golf and Country Club. Best Drug Rehabilitation staff members were delighted to ... helping underprivileged children. Kiwanis International, the parent of the Manistee Kiwanis Club, is a ...
Breaking Medicine News(10 mins):Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Amica Insurance Has 7 Summer Safety Tips 2Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2
... (HealthDay News) -- A treatment currently being studied may ... build-up of plaque in artery walls that can lead ... conducting the study, published in the Sept. 12 issue ... with atherosclerosis who were randomly assigned to be treated ...
... Depression to Their Physicians , Many adults subscribe to ... to their primary care physician. In a survey of ... more reasons for not talking to a primary care ... reason being concern the physician would recommend antidepressants (23 ...
... HealthDay Reporter , MONDAY, Sept. 12 (HealthDay News) ... men become fathers, perhaps because they don,t need to compete ... bonding with their children. The findings don,t prove that ... the hormonal systems in men may detect that they,ve become ...
... new, minimally invasive way of treating irregular heartbeats by ... one such heart rhythm disorder, and it,s the most ... 70 percent of patients with the disorder who were ... of any heart rhythm irregularities one year out from ...
... By Dennis Thompson HealthDay Reporter , MONDAY, Sept. ... to check for colon cancer will become the standard screening ... slam-dunk. The method, known as virtual colonoscopy, combines X-ray ... length of the colon, the large intestine. It allows doctors ...
... Steven Reinberg HealthDay Reporter , MONDAY, Sept. 12 ... (NSAIDs) such as Advil, Motrin and Aleve may slightly increase ... Millions of people use these drugs regularly for pain and ... cancers, the researchers added. "NSAIDs have been associated ...
Cached Medicine News:Health News:New Drug Boosts 'Good' Cholesterol in Study Patients 2Health News:September/October 2011 Annals of Family Medicine Tip Sheet 2Health News:September/October 2011 Annals of Family Medicine Tip Sheet 3Health News:September/October 2011 Annals of Family Medicine Tip Sheet 4Health News:September/October 2011 Annals of Family Medicine Tip Sheet 5Health News:September/October 2011 Annals of Family Medicine Tip Sheet 6Health News:September/October 2011 Annals of Family Medicine Tip Sheet 7Health News:September/October 2011 Annals of Family Medicine Tip Sheet 8Health News:Testosterone Levels Seem to Fall With Fatherhood 2Health News:Testosterone Levels Seem to Fall With Fatherhood 3Health News:Freeze and desist: Disabling cardiac cells that can cause arrhythmia 2Health News:Virtual Colonoscopy Still Has Its Skeptics 2Health News:Virtual Colonoscopy Still Has Its Skeptics 3Health News:Virtual Colonoscopy Still Has Its Skeptics 4Health News:NSAID Painkillers Linked to Risk of Kidney Cancer 2Health News:NSAID Painkillers Linked to Risk of Kidney Cancer 3
Replacement bulb for Vibratome light system....
These specialty razor blades are feather thin and very sharp. Most users have found an increased quality level in Vibratome sections with these blades....
The care package includes a spare motor, fuse, Spare Fluorescent Bulb, additional Vibratome Feather Blades, Specimen Adhesive, Specimen Mounting Blocks, and a Specimen Tray....
... The Specimen Tray accessory fits inside the existing ... working area for tissue sectioning. Specimens are ... tray. This is a great option if ... expensive buffer, or wish to utilize the black ...
Medicine Products: